Mederi-RF manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. Their line of minimally invasive tools and therapies, including the Dx-pH System, Stretta, and Secca, helps accurately diagnose, manage, and treat reflux disorders. These outpatient solutions provide targeted treatment for reflux, with a focus on data-driven approaches for clinicians and personalized therapy options for patients. Mederi-RF's products aim to reduce reflux symptoms, strengthen the lower esophageal sphincter, and offer alternative solutions for individuals who do not find relief from medication or prefer to avoid surgery.